Illustration of a modern chemical manufacturing facility with molecular structures blending into financial charts as a CEO purchases company stock ahead of Huntsman's proposed $12.5 billion merger with Olin, symbolizing long-term value investing.

🧪 Huntsman (HUN): CEO Buys $981K as Wall Street Overlooks a $12 Billion Chemical Merger

Huntsman isn't simply a cyclical chemical company anymore. Between repeated insider buying, a transformational $12.5 billion merger with Olin, trading at just 0.64x book value and more than $400 million in projected synergies, investors may be looking at one of the market's more intriguing industrial turnaround opportunities.

Read entire article

Cartoon of Olin directors holding bleach bottles in one hand and bullets in the other, with a puzzled investor standing between them, wondering whether to buy the stock.

Can Olin Cock Its Stock? Insiders Say Yes (Lock, Load, and Maybe Profit)

Olin ($OLN) insiders are loading up on shares while institutions already own 94% of the float. Profits are weak, ammo is hot, and bleach is… bleach. Can this 132-year-old company cock its stock for a rebound?

 

Read entire article